omeprazole has been researched along with Weight Gain in 10 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The impact of omeprazole (OM), a widely used over-the-counter proton pump inhibitor, on weight gain has not been extensively explored." | 7.85 | Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background. ( Gillilland, MG; Merchant, JL; Saqui-Salces, M; Tsao, AC, 2017) |
| "The body weight gain was suppressed by omeprazole treatment." | 7.71 | Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. ( Chen, D; Cui, GL; Syversen, U; Waldum, HL; Zhao, CM, 2001) |
| "The body weight gain was suppressed by omeprazole treatment." | 3.71 | Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. ( Chen, D; Cui, GL; Syversen, U; Waldum, HL; Zhao, CM, 2001) |
| "The results indicate that omeprazole treatment in chickens leads not only to trophic effects in the acid-producing gastric mucosa (probably because of the ensuing hypergastrinemia), as reported earlier, but also to growth of the parathyroid glands (both hypertrophy and hyperplasia) and to bone loss without affecting blood calcium values." | 3.69 | Growth of the parathyroid glands in omeprazole-treated chickens. ( Gagnemo-Persson, R; Håkanson, R; Persson, P; Sundler, F, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saqui-Salces, M | 1 |
| Tsao, AC | 1 |
| Gillilland, MG | 1 |
| Merchant, JL | 1 |
| Cohen, H | 1 |
| Tomasso, G | 1 |
| Luisa Cafferata, M | 1 |
| Zapata, C | 1 |
| Sharma, P | 1 |
| Armstrong, D | 1 |
| Moraes-Filho, JP | 1 |
| Blasco, C | 1 |
| Corti, R | 1 |
| Estape, G | 1 |
| Leite Luna, L | 1 |
| Ortuño, R | 1 |
| Sakai, P | 1 |
| Salis, G | 1 |
| Taullard, D | 1 |
| Trakal, E | 1 |
| Valdovinos, M | 1 |
| Vergara, M | 1 |
| Gónzalez, O | 1 |
| Yoshikawa, I | 1 |
| Nagato, M | 1 |
| Yamasaki, M | 1 |
| Kume, K | 1 |
| Otsuki, M | 1 |
| Gagnemo-Persson, R | 1 |
| Håkanson, R | 1 |
| Sundler, F | 1 |
| Persson, P | 1 |
| Barraclough, M | 1 |
| Taylor, CJ | 1 |
| Hinrichsen, JP | 1 |
| Neira, M | 1 |
| Lopez, C | 1 |
| Chiong, M | 1 |
| Ocaranza, MP | 1 |
| Gallardo, R | 1 |
| Rutman, M | 1 |
| Blamey, J | 1 |
| Lavandero, S | 1 |
| Srinivasan, R | 1 |
| Minocha, A | 1 |
| Støa-Birketvedt, G | 1 |
| Løvhaug, N | 1 |
| Vonen, B | 1 |
| Florholmen, J | 1 |
| Cui, GL | 1 |
| Syversen, U | 1 |
| Zhao, CM | 1 |
| Chen, D | 1 |
| Waldum, HL | 1 |
| Raoul, JL | 1 |
| Bretagne, JF | 1 |
| Ropert, A | 1 |
| Siproudhis, L | 1 |
| Heresbach, D | 1 |
| Gosselin, M | 1 |
1 review available for omeprazole and Weight Gain
| Article | Year |
|---|---|
Latin american consensus on gastroesophageal reflux disease: an update on therapy.
Topics: Alginates; Antacids; Anti-Ulcer Agents; Cohort Studies; Consensus; Dose-Response Relationship, Drug; | 2010 |
9 other studies available for omeprazole and Weight Gain
| Article | Year |
|---|---|
Weight gain in mice on a high caloric diet and chronically treated with omeprazole depends on sex and genetic background.
Topics: Adiposity; Animals; Diet, High-Fat; Energy Intake; Energy Metabolism; Feeding Behavior; Female; Gast | 2017 |
Long-term treatment with proton pump inhibitor is associated with undesired weight gain.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Blood Pressure; Body Mass Index; Body Weight; Case-Co | 2009 |
Growth of the parathyroid glands in omeprazole-treated chickens.
Topics: Animals; Bone Density; Chickens; DNA; Gastrins; Hyperplasia; Hypertrophy; Omeprazole; Organ Size; Pa | 1994 |
Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption.
Topics: Absorption; Acids; Child; Child, Preschool; Circadian Rhythm; Cystic Fibrosis; Dietary Fats; Duodenu | 1996 |
Omeprazole, a specific gastric secretion inhibitor on oxynticopeptic cells, reduces gizzard erosion in broiler chicks fed with toxic fish meals.
Topics: Administration, Oral; Animal Feed; Animals; Anti-Ulcer Agents; Chickens; Dose-Response Relationship, | 1997 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esop | 1997 |
H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; | 1997 |
Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats.
Topics: Age Factors; Animals; Anti-Ulcer Agents; Bone Diseases, Metabolic; Calcification, Physiologic; Enter | 2001 |
Zollinger-Ellison syndrome, antisecretory treatment, and body weight.
Topics: Body Weight; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole | 1992 |